Objective: To determine the effect of concomitant medical diseases on
bleeding duodenal ulcer patients. Methods: A retrospective analysis of
all bleeding duodenal ulcer patients admitted to King Khalid Universi
ty Hospital between 1412 and 1416 H. patients were included in the stu
dy if they;had, at endoscopy, actively bleeding duodenal ulcer, or gas
troscopy showed evidence of stigmata of recent hemorrhage from duodena
l ulcer. Patients were excluded if bleeding site was not identified, p
resence of another source of bleeding or malignant ulcer. Results: Rec
ords of fifty four patients fullfilled the criteria for inclusion. Twe
nty patients (Group I) were suffering from bleeding duodenal ulcer alo
ne (control group), while thirty four patients were diagnosed to have
bleeding duodenal ulcer as well as a significant underlying medical di
sorder (Group II). All patients received endoscopic adrenaline injecti
on to achieve heamostasis. Group II patients were significantly older,
stayed longer in hospital and had increased mortality P = 0.0001, 0.0
04 and 0.007 respectively. Rebleeding rate was also more common but st
atistically not significant in Group II 20.6% V15% P = 0.8. Conclusion
: Co-existing medical diseases adversely affect the outcome of bleedin
g duodenal ulcer patients.